REGENXBIO Inc — Cash Flow (NASDAQ:RGNX) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 54.06 M218.88 M207.49 M218.41 M173.13 M 103.3 M Cash from investing activities 122.76 M406.64 M11.93 M190.94 M103.45 M 93.68 M Cash from financing activities 200.21 M195.25 M28.84 M34.97 M92.68 M 118.61 M Free cash flow 27.19 M134.7 M176.76 M208.45 M170.69 M 100.31 M

Notícias

Stifel comenta ações da uniQure após declarações do comissário da FDA

Stifel comments on uniQure shares after FDA commissioner remarks

Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug

Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com

REGENXBIO: Cautiously Bullish After FDA Setbacks (NASDAQ:RGNX)

Regenxbio stock price target lowered to $32 at H.C. Wainwright after FDA rejection

Intel, Wells Fargo among market cap stock movers on Tuesday

Netflix and Oracle among market cap stock movers on Tuesday

Regenxbio stock price target lowered by Goldman Sachs on RGX-121 setback

Ações da REGENXBIO caem após FDA rejeitar terapia gênica para síndrome de Hunter

After-hours movers: ON Semiconductor, Credo, Upwork, Regenxbio, and more